[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Lifemd Inc (LFMD)

Lifemd Inc (LFMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 158,581
  • Shares Outstanding, K 48,201
  • Annual Sales, $ 194,060 K
  • Annual Income, $ 14,350 K
  • EBIT $ -25 M
  • EBITDA $ -18 M
  • 60-Month Beta 2.02
  • Price/Sales 0.84
  • Price/Cash Flow N/A
  • Price/Book 20.52

Options Overview Details

View History
  • Implied Volatility 82.11% (+0.72%)
  • Historical Volatility 68.62%
  • IV Percentile 25%
  • IV Rank 21.69%
  • IV High 152.07% on 02/19/26
  • IV Low 62.73% on 08/15/25
  • Expected Move (DTE 8) 0.26 (7.37%)
  • Put/Call Vol Ratio 1.00
  • Today's Volume 1,446
  • Volume Avg (30-Day) 1,232
  • Put/Call OI Ratio 0.25
  • Today's Open Interest 50,249
  • Open Int (30-Day) 45,285
  • Expected Range 3.21 to 3.72

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $-0.04
  • Number of Estimates 2
  • High Estimate $-0.03
  • Low Estimate $-0.05
  • Prior Year $-0.10
  • Growth Rate Est. (year over year) +60.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.00 +15.33%
on 08/06/26
4.79 -27.77%
on 07/14/26
-1.30 (-27.31%)
since 07/13/26
3-Month
3.00 +15.33%
on 08/06/26
5.23 -33.84%
on 06/09/26
-1.08 (-23.79%)
since 05/13/26
52-Week
2.56 +35.16%
on 02/24/26
7.32 -52.73%
on 10/03/25
-3.43 (-49.78%)
since 08/13/25

Most Recent Stories

More News
UPDATE - LifeMD Reports Second Quarter 2026 Results

UPDATE this press release has been updated to remove a duplicate table. Second quarter 2026 revenue of $47.3 million, within the Company’s guidance range of $47 million to $50 million; adjusted...

LFMDP : 23.52 (+0.02%)
LFMD : 3.46 (+5.17%)
LifeMD Reports Second Quarter 2026 Results

Second quarter 2026 revenue of $47.3 million, within the Company’s guidance range of $47 million to $50 million; adjusted EBITDA loss of approximately $3.5 million, improving approximately 21% sequentially....

LFMDP : 23.52 (+0.02%)
LFMD : 3.46 (+5.17%)
LifeMD to Report Second Quarter 2026 Financial Results on August 5

NEW YORK, July 24, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD) , a leading provider of virtual primary care services, announces that it will report financial results for the three and six months...

LFMDP : 23.52 (+0.02%)
LFMD : 3.46 (+5.17%)
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

NEW YORK, June 23, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading direct-to-patient telehealth company, today announced that its Board of Directors has authorized a cash dividend...

LFMDP : 23.52 (+0.02%)
LFMD : 3.46 (+5.17%)
LifeMD Announces Exclusive Collaboration to Launch Direct-to-Patient Self-Pay Program for XYOSTED® (testosterone enanthate) Injection

Landmark agreement between a leading virtual care company and a pharmaceutical manufacturer establishes an exclusive telehealth co-marketing arrangement with LifeMD for the XYOSTED self-pay program, launching...

LFMDP : 23.52 (+0.02%)
LFMD : 3.46 (+5.17%)
LifeMD Appoints Umesh Sripad as Chief Technology Officer

NEW YORK, June 01, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading direct-to-patient telehealth company, today announced the appointment of Umesh Sripad as Chief Technology Officer (CTO),...

LFMDP : 23.52 (+0.02%)
LFMD : 3.46 (+5.17%)
LifeMD to Participate in Upcoming Investor Conferences

NEW YORK, May 15, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading platform for virtual primary care services, today announced that management will be participating in two upcoming...

LFMDP : 23.52 (+0.02%)
LFMD : 3.46 (+5.17%)
LifeMD Reports First Quarter 2026 Results

First quarter 2026 revenue of $50.2 million and adjusted EBITDA loss of $4.5 million, above and in line, respectively, with the Company’s guidance. Gross margin increased approximately 420 basis points...

LFMDP : 23.52 (+0.02%)
LFMD : 3.46 (+5.17%)
LifeMD to Report First Quarter 2026 Financial Results on May 6

NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD) , a leading provider of virtual primary care services, announces that it will report financial results for the three months...

LFMDP : 23.52 (+0.02%)
LFMD : 3.46 (+5.17%)
LifeMD® Now Offering Eli Lilly and Company’s Foundayo™ (orforglipron), a New GLP-1 Pill for Weight Management

NEW YORK, April 10, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that it is now offering Foundayo ™ (orforglipron)...

LFMDP : 23.52 (+0.02%)
LFMD : 3.46 (+5.17%)

Business Summary

LifeMD Inc. is a telehealth company. It offers a full portfolio of direct-to-patient products and services. The company combines virtual medical treatment with prescription medications and unique over-the-counter products. Its network of licensed physicians offers telemedicine services and direct-to-consumer...

See More

Key Turning Points

3rd Resistance Point 3.75
2nd Resistance Point 3.61
1st Resistance Point 3.54
Last Price 3.46
1st Support Level 3.33
2nd Support Level 3.19
3rd Support Level 3.12

See More

52-Week High 7.32
Fibonacci 61.8% 5.50
Fibonacci 50% 4.94
Fibonacci 38.2% 4.38
Last Price 3.46
52-Week Low 2.56

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.